The Early- and Intermediate-Term Toxicity to Primitive Hematopoietic Progenitor Cells of Three Chemotherapy Regimens for Advanced Hodgkin Lymphoma
- 1 December 2009
- journal article
- Published by Elsevier BV in Clinical Lymphoma Myeloma and Leukemia
- Vol. 9 (6), 425-429
- https://doi.org/10.3816/clm.2009.n.084
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Bone marrow stem cell damage after three different chemotherapy regimens for advanced Hodgkin's lymphoma.Oncology Reports, 2009
- ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi TrialJournal of Clinical Oncology, 2009
- Long-term lymphoma survivors following high-dose chemotherapy and autograft: Evidence of permanent telomere shortening in myeloid cells, associated with marked reduction of bone marrow hematopoietic stem cell reservoirExperimental Hematology, 2007
- MOPPEBVCAD Chemotherapy with Limited and Conditioned Radiotherapy in Advanced Hodgkin's Lymphoma: 10-Year Results, Late Toxicity, and Second TumorsClinical Cancer Research, 2006
- Standard and Increased-Dose BEACOPP Chemotherapy Compared with COPP-ABVD for Advanced Hodgkin's DiseaseThe New England Journal of Medicine, 2003
- Chromosome and Molecular Abnormalities in Myelodysplastic SyndromesInternational Journal of Hematology, 2001
- Kinetics of committed and primitive blood progenitor mobilization after chemotherapy and growth factor treatment and their use in autotransplantsBlood, 1994
- Chemotherapy of Advanced Hodgkin's Disease with MOPP, ABVD, or MOPP Alternating with ABVDThe New England Journal of Medicine, 1992
- The long-term effects of MVPP chemotherapy for Hodgkin's disease on bone marrow functionBritish Journal of Cancer, 1990
- Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPPCancer, 1975